Nevin Çelebi

2.3k citations
61 papers · 1.8k indexed · h-index 25

Nevin Çelebi

60 papers receiving 1.7k citations

Peers

Nevin Çelebi
Comparison fields: 5 of 125
  • Pharmaceutical Science 871
  • Rehabilitation 359
  • Biomaterials 430
  • Drug Discovery 4
  • Molecular Medicine 85
Replace Abid Mehmood Yousaf with:
Abid Mehmood Yousaf Pakistan
Narendar Dudhipala United States
Vineet Kumar India
Veera Venkata Satyanarayana Reddy Karri India
Neslihan Üstündağ Okur Türkiye
Yasser Shahzad Pakistan
Manju Rawat Singh India
Nabil K. Alruwaili Saudi Arabia
Labiba K. El‐Khordagui Egypt
Mohammadreza Abbaspour Iran
Nevin Çelebi relative to Abid Mehmood Yousaf Pakistan Abid Mehmood Yousaf's profile →
Citations per field
00.5×1.7×
Abid Mehmood Yousaf · 1×
Citations per year

Countries citing papers authored by Nevin Çelebi

Since Specialization
Citations

This map shows the geographic impact of Nevin Çelebi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nevin Çelebi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nevin Çelebi more than expected).

Fields of papers citing papers by Nevin Çelebi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nevin Çelebi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nevin Çelebi. The network helps show where Nevin Çelebi may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Nevin Çelebi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Nevin Çelebi Line = papers co-authored together Nevin Çelebi links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20241
2 202357
3 202124
4 20217
5 20203
6 202040
7 20205
8 202013
9 201957
10 201662
11 201429
12 201324
13 201170
14 2006252
15 200422
16 200238
17 2002101
18 200214
19 200227
20 199527

About Nevin Çelebi

Nevin Çelebi is a scholar working on Pharmaceutical Science, Rehabilitation and Pharmacology, having authored 61 papers that have together received 1.8k indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (34 papers), Advanced Drug Delivery Systems (28 papers), Advancements in Transdermal Drug Delivery (18 papers), Wound Healing and Treatments (8 papers), Protein purification and stability (7 papers), Surfactants and Colloidal Systems (5 papers), Analytical Chemistry and Chromatography (4 papers) and Crystallization and Solubility Studies (4 papers). The work is most often cited by research in Pharmaceutical Science (871 citations), Rehabilitation (359 citations) and Biomaterials (430 citations). Nevin Çelebi has collaborated with scholars based in Türkiye, Serbia and Kazakhstan. Frequent co-authors include Alptuğ Karaküçük, Zelihagül Değim, Deniz Erdoğan, İsmail Tuncer Değim, Sibel Ilbasmiş-Tamer, Serdar Öztürk, Fatih Zor, Zeynep Şafak Teksin, Candan Özoğul and Aydan Babül. Their work appears in journals such as SHILAP Revista de lepidopterología, Journal of Controlled Release and International Journal of Pharmaceutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026